Immunovant, Inc. (IMVT) Social Stream



Immunovant, Inc. (IMVT): $6.76

-0.22 (-3.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IMVT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 461

in industry

Immunovant Inc (IMVT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMVT.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
8 $22 $9 $13.285 $8.02 65.65%
7 $22 $10 $14 $8.02 74.56%
8 $22 $10 $14 $8.02 74.56%

The Trend in the Analyst Price Target


IMVT's average price target has moved down $8.59 over the prior 28 weeks.

IMVT reports an average of 110.02% for its upside potential over the past 52 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-05 8 22 9 13.285 7.61 74.57%
2021-09-04 9 32 7 18.000 9.01 99.78%
2021-06-26 10 55 9 21.880 11.41 91.76%
2021-03-20 11 55 26 39.100 17.00 130%
2021-01-09 NA 67 49 58.270 NA NA%

IMVT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 5 0 3 0 0 8

The Trend in the Broker Recommendations


Over the past 153 days, IMVT's average broker recommendation rating improved by 0.36.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMVT as an investment opportunity.

  • IMVT has a lower variance in analysts' estimates than -174.09% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Immunovant Inc's average analyst price target is greater than 45.69% of them.
  • In terms of how Immunovant Inc fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 231.27% of that group.
  • In the context of Pharmaceutical Products stocks, Immunovant Inc's number of analysts covering the stock is higher than 207.24% of them.

Stocks similar to Immunovant Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AGIO, FOLD and VYGR.

Make investment decisions regarding IMVT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9396 seconds.